QTc Study GSK573719+GW642444

NCT01521377 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Placebo Moxifloxacin
DRUG: Moxifloxacin
DRUG: GSK573719/Vilanterol 125/25mcg
DRUG: GSK573719
DRUG: GSK573719/Vilanterol 500/100mcg
DRUG: Placebo DPI

Sponsor

GlaxoSmithKline